Related Experiment Video
Updated: Jun 7, 2026

08:17
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
Long term survival in aggressive NK cell leukemia.
Ashwin P Patel1, Somsuvra B Ghatak, Jagruti A Patel
1Gujarat Research and Medical Institute, Shahibaug, Ahmedabad 380 004, India. rutviap@hotmail.com
Indian Pediatrics
|November 5, 2010
Summary
Aggressive natural killer cell leukemia (ANKL) is a rare, aggressive cancer. This report details a pediatric ANKL case achieving four-year remission, offering hope for improved outcomes.
Area of Science:
- Hematology
- Pediatric Oncology
- Immunology
Background:
- Aggressive natural killer cell leukemia (ANKL) is a rare hematologic malignancy.
- ANKL is characterized by rapid progression and a poor prognosis, often with limited survival.
- There is a significant lack of reported cases of ANKL within the Indian pediatric population.
Observation:
- This study presents a unique case of ANKL in a pediatric patient.
- The patient was diagnosed with aggressive natural killer cell leukemia.
- The case highlights a rare occurrence in the Indian pediatric literature.
Findings:
- The pediatric ANKL case reported herein has achieved complete continuous remission.
- The remission has been sustained for a duration of four years.
- This represents a significant and prolonged positive outcome for a typically aggressive disease.
Implications:
- This case suggests that long-term remission in pediatric ANKL is achievable.
- The findings may encourage further research into treatment strategies for ANKL in children.
- Successful management of this rare leukemia in a pediatric patient could improve future therapeutic approaches and patient outcomes.

